GWSA
BCAB icon

Global Wealth Strategies & Associates’s BioAtla BCAB Stock Holding History

Global Wealth Strategies & Associates’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-275
Closed -$7.82K – 549
2025
Q4 		$7.82K Hold
275
– – ﹤0.01% 332
2025
Q3 		$9.47K Hold
275
– – ﹤0.01% 290
2025
Q2 		$5.45K Hold
275
– – ﹤0.01% 257
2025
Q1 		$4.78K Hold
275
– – ﹤0.01% 320
2024
Q4 		$8.14K Buy
+275
New +$23.1K ﹤0.01% 239

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Global Wealth Strategies & Associates's BCAB Position: Q1 2026 in Review

Global Wealth Strategies & Associates sold out of BioAtla (BCAB) in Q1 2026, closing a stake of 275 shares — an estimated $7.82K sold.

Global Wealth Strategies & Associates first reported a position in BCAB in Q4 2024 and held it in 5 quarters. The position peaked at $9.47K in Q3 2025. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

  • Global Wealth Strategies & Associates reported no remaining BioAtla position as of Q1 2026 after selling out during the quarter.
  • Global Wealth Strategies & Associates sold 275 BioAtla shares in Q1 2026, an estimated $7.82K.
  • Global Wealth Strategies & Associates first reported a position in BioAtla in Q4 2024 and held it in 5 quarters.
  • Global Wealth Strategies & Associates's BioAtla position peaked at $9.47K in Q3 2025.
  • 36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on Global Wealth Strategies & Associates's 13F filing for Q1 2026, filed 3 Apr 2026.